Literature DB >> 15852355

Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface.

Arnaud Vonarbourg1, Patrick Saulnier, Catherine Passirani, Jean-Pierre Benoit.   

Abstract

Lipid nanocapsules (LNCs) containing poly(ethylene glycol) (PEG) were developed according to a phase inversion process without organic solvent. The distribution of PEG chains at the surface was determined due to electrokinetic properties, in order to correlate it with protein adsorption potentiality. In this aim, electrophoretic mobilities were measured as a function of ionic strength and pH, for particles differing by their size, dialysis effects, and the presence or not of lecithin in their shell. The study allowed the determination of the isoelectric point (pI) as well as the charge density (ZN) in relation with the dipolar distribution in the polyelectrolyte accessible layer (depth = 1/lambda), by using soft-particle electrophoresis analysis. These parameters pointed out that the PEG surface organization was dependent on the particle size. Moreover, this organization could be modified by dialyzing particles and/or by formulating them with or without lecithin. Lecithin was found to be present in the inner part of the polyelectrolyte layer and to play a role in the outer part disorganization. Dialyzing LNCs formulated with lecithin allowed to obtain stable and well-structured nanocapsules, ready to an in vivo use as drug delivery system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852355     DOI: 10.1002/elps.200410145

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  13 in total

1.  Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties.

Authors:  Arnaud Béduneau; Patrick Saulnier; Nicolas Anton; François Hindré; Catherine Passirani; Holisoa Rajerison; Nicolas Noiret; Jean-Pierre Benoit
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

2.  Tissue distribution of indinavir administered as solid lipid nanocapsule formulation in mdr1a (+/+) and mdr1a (-/-) CF-1 mice.

Authors:  Manuela Pereira de Oliveira; Emmanuel Garcion; Nicolas Venisse; Jean-Pierre Benoit; William Couet; Jean-Christophe Olivier
Journal:  Pharm Res       Date:  2005-11       Impact factor: 4.200

3.  Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.

Authors:  Ngoc Trinh Huynh; Marie Morille; Jerome Bejaud; Pierre Legras; Anne Vessieres; Gerard Jaouen; Jean-Pierre Benoit; Catherine Passirani
Journal:  Pharm Res       Date:  2011-06-21       Impact factor: 4.200

4.  Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent.

Authors:  Catherine Chapon; Florence Franconi; Franck Lacoeuille; François Hindré; Patrick Saulnier; Jean-Pierre Benoit; Jean-Jacques Le Jeune; Laurent Lemaire
Journal:  MAGMA       Date:  2008-12-24       Impact factor: 2.310

5.  Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers.

Authors:  Archibald Paillard; Catherine Passirani; Patrick Saulnier; Maya Kroubi; Emmanuel Garcion; Jean-Pierre Benoît; Didier Betbeder
Journal:  Pharm Res       Date:  2009-10-23       Impact factor: 4.200

6.  Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.

Authors:  Jaleh Varshosaz; Somayeh Taymouri; Ali Jahanian-Najafabadi; Arezoo Alizadeh
Journal:  IET Nanobiotechnol       Date:  2018-09       Impact factor: 1.847

7.  DNA nanocarriers for systemic administration: characterization and in vivo bioimaging in healthy mice.

Authors:  Stephanie David; Catherine Passirani; Nathalie Carmoy; Marie Morille; Mathieu Mevel; Benoit Chatin; Jean-Pierre Benoit; Tristan Montier; Bruno Pitard
Journal:  Mol Ther Nucleic Acids       Date:  2013-01-08       Impact factor: 10.183

8.  Lipid nanocapsule-based gels for enhancement of transdermal delivery of ketorolac tromethamine.

Authors:  Jaleh Varshosaz; Valiollah Hajhashemi; Sindokht Soltanzadeh
Journal:  J Drug Deliv       Date:  2011-11-17

Review 9.  Developments in the use of nanocapsules in oncology.

Authors:  V Yurgel; T Collares; F Seixas
Journal:  Braz J Med Biol Res       Date:  2013-05-28       Impact factor: 2.590

10.  Surface active properties of lipid nanocapsules.

Authors:  Celia R A Mouzouvi; Anita Umerska; André K Bigot; Patrick Saulnier
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.